1. Home
  2. RPRX vs KIM Comparison

RPRX vs KIM Comparison

Compare RPRX & KIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • KIM
  • Stock Information
  • Founded
  • RPRX 1996
  • KIM 1958
  • Country
  • RPRX United States
  • KIM United States
  • Employees
  • RPRX N/A
  • KIM N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • KIM Real Estate Investment Trusts
  • Sector
  • RPRX Health Care
  • KIM Real Estate
  • Exchange
  • RPRX Nasdaq
  • KIM Nasdaq
  • Market Cap
  • RPRX 16.2B
  • KIM 14.1B
  • IPO Year
  • RPRX 2020
  • KIM 1991
  • Fundamental
  • Price
  • RPRX $39.75
  • KIM $20.58
  • Analyst Decision
  • RPRX Strong Buy
  • KIM Buy
  • Analyst Count
  • RPRX 3
  • KIM 11
  • Target Price
  • RPRX $46.00
  • KIM $24.45
  • AVG Volume (30 Days)
  • RPRX 3.5M
  • KIM 5.3M
  • Earning Date
  • RPRX 11-05-2025
  • KIM 10-30-2025
  • Dividend Yield
  • RPRX 2.26%
  • KIM 5.03%
  • EPS Growth
  • RPRX N/A
  • KIM 57.13
  • EPS
  • RPRX 1.75
  • KIM 0.83
  • Revenue
  • RPRX $2,349,844,000.00
  • KIM $2,123,057,000.00
  • Revenue This Year
  • RPRX $36.16
  • KIM $4.86
  • Revenue Next Year
  • RPRX $2.04
  • KIM $3.18
  • P/E Ratio
  • RPRX $22.24
  • KIM $24.88
  • Revenue Growth
  • RPRX 3.70
  • KIM 8.14
  • 52 Week Low
  • RPRX $24.05
  • KIM $17.93
  • 52 Week High
  • RPRX $41.24
  • KIM $25.83
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 62.74
  • KIM 40.09
  • Support Level
  • RPRX $38.39
  • KIM $20.16
  • Resistance Level
  • RPRX $41.24
  • KIM $20.60
  • Average True Range (ATR)
  • RPRX 1.22
  • KIM 0.42
  • MACD
  • RPRX 0.18
  • KIM -0.08
  • Stochastic Oscillator
  • RPRX 71.92
  • KIM 23.00

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About KIM Kimco Realty Corporation (HC)

One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.

Share on Social Networks: